Enabling access to new WHO essential medicines: the case for nicotine replacement therapies
نویسندگان
چکیده
Nicotine replacement therapies (NRT) are powerful tools for the successful treatment of nicotine addiction and tobacco use. The medicines are clinically effective, supported by the Framework Convention on Tobacco Control, and are now World Health Organization-approved essential medicines. Enabling global access to NRT remains a challenge given ongoing confusion and misperceptions about their efficacy, cost-effectiveness, and availability with respect to other tobacco control and public health opportunities. In this commentary, we review existing evidence and guidelines to make the case for global access to NRT highlighting the smoker's right to access treatment to sensibly address nicotine addiction.
منابع مشابه
Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria
Background Prompt and effective case detection and treatment are vital components of the malaria case management strategy as malaria-endemic countries implement the testing, treating and tracking policy. The implementation of this policy in public and formal private sectors continue to receive great attention while the informal private retail sector (mostly the patent and propriety medicine ven...
متن کاملImpact of UK policy initiatives on use of medicines to aid smoking cessation.
CONTEXT Increasing the use of effective smoking cessation aids could in principle have a substantial public health impact. The UK government has undertaken several major policy initiatives to try to increase usage of smoking cessation medicines. It is important to evaluate what effect, if any, these have had to inform future policy in the UK and internationally. OBJECTIVE This study used sale...
متن کاملRegulation of nicotine replacement therapies (NRT): a critique of current practice.
Nicotine replacement therapy (NRT) describes a group of products delivering nicotine that are licensed for the relief of withdrawal as an aid to smoking cessation. This paper examines areas where public health considerations suggest changes should be made to the current indications and characteristics for NRT products. It is argued that the current regulatory framework restricts access to NRT w...
متن کاملEffect of the HIV epidemic on liver cancer in Africa.
Harm reduction by use of buccalabsorption tobacco products (smokeless tobacco) is at the centre of the debate among health professionals dealing with tobacco-related issues, but uncertainties prevail. John Britton and Richard Edwards (Feb 2, p 441) suggest the establishment of a national nicotine regulatory authority. Nicotine replacement therapies reduce cigarette consumption, but we still do ...
متن کاملWas the expansion of the marketing license for nicotine replacement therapy in the United kingdom to include smoking reduction associated with changes in use and incidence of quit attempts?
BACKGROUND In December 2009 and January 2010, the UK Medicines and Healthcare Products Regulatory Agency expanded the marketing license for a number of nicotine replacement therapies (NRTs) to include smoking reduction without an intention to stop completely. This study examined whether this was associated with a change in incidence of use of NRT for harm reduction (i.e., smoking reduction and/...
متن کامل